Search

everythinglearnresearchcommunity

for

Search:↓

Reducing 5α-reductase activity helps endometrial cells differentiate, aiding pregnancy.

Blocking 11β-HSD1 reduces stress hormone damage in hair growth cells.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

PDCD4 is important for controlling skin cell growth and healing.

A compound from brown algae boosts the production of a certain inflammatory substance in skin cells.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Increased energy use in Pik3r1-related insulin resistance isn't due to Ucp1 thermogenesis.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

Caffeine and DMG increase calcium influx in hair follicle cells without being toxic.

Bifidobacterium animalis subsp. lactis J12 helps reduce atopic dermatitis symptoms.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

Enzymes called PADIs play a key role in hair growth and loss.

Blocking DGAT1 reduces oil gland size in mice and dogs, but only mice experience hair loss.

Dutasteride may protect the brain in early Parkinson's disease.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

Dopamine stops hair growth and pigment production in human scalp hair follicles.

D-004 may be a natural alternative to finasteride for treating enlarged prostate and male baldness.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.